Mangoceuticals Stock (NASDAQ:MGRX)

Revenue Ownership Financials Chart

Previous Close

$0.38

52W Range

$0.16 - $2.75

50D Avg

$0.39

200D Avg

$0.92

Market Cap

$4.32M

Avg Vol (3M)

$1.24M

Beta

2.27

Div Yield

MGRX Company Profile

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Mar 21, 2023

Website

MGRX Performance

MGRX Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$304.81K	$615.87K	$731.49K
Operating Income	$-18.03M	$-7.97M	$-9.22M
Net Income	$-20.64M	$-8.71M	$-9.21M
EBITDA	$-18.03M	$-7.96M	$-8.09M
Basic EPS	$-2.05	$-4.40	$-8.58
Diluted EPS	$-2.05	$-4.40	$-8.58

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
ASBP	Aspire Biopharma Holdings, Inc.
HCTI	Healthcare Triangle, Inc.
FEMY	Femasys Inc.
VSEE	VSee Health, Inc.
TOI	The Oncology Institute, Inc.
CLSD	Clearside Biomedical, Inc.
CING	Cingulate Inc.
PALI	Palisade Bio, Inc.